Association of overhydration and serum pigment epithelium-derived factor with CKD progression in diabetic kidney disease: A prospective cohort study.
Diabetes Mellitus, Type 2
/ physiopathology
Diabetic Nephropathies
/ complications
Disease Progression
Eye Proteins
/ blood
Female
Glomerular Filtration Rate
Humans
Kidney Failure, Chronic
/ blood
Male
Middle Aged
Nerve Growth Factors
/ blood
Prognosis
Prospective Studies
Risk Factors
Serpins
/ blood
Survival Rate
Water-Electrolyte Imbalance
/ complications
Albuminuria
Body composition
Chronic kidney disease
Type 2 diabetes
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
22
12
2020
revised:
03
03
2021
accepted:
07
03
2021
pubmed:
21
3
2021
medline:
18
5
2021
entrez:
20
3
2021
Statut:
ppublish
Résumé
Little is known about whether overhydration (OH), measured using bioimpedance assay (BIA), is associated with CKD progression in patients with type 2 diabetes mellitus (T2DM). We hypothesised that OH was a predictor, and pigment epithelium-derived factor (PEDF) was a modifiable risk factor of CKD progression. We conducted a prospective cohort study of 1,065 patients with clinically euvolemic T2DM who attended the diabetes centre in a tertiary hospital or primary care clinic. CKD progression was defined as a combination of the worsening of the KDIGO defined CKD category by eGFR and a ≥25% decline in eGFR compared to baseline. Patients with T2DM in the highest tertile of OH and relative OH (OH/ extracellular water > 7%) were positively associated with CKD progression (hazard ratio [HR] 1.45 [95% confidence interval (CI) 1.14-1.85; p = 0.003 and HR 1.29 [95%CI 1.05-1.59; p = 0.017]). There were positive associations between PEDF and CKD progression (β = 1.10; p = 0.001) and between OH and CKD progression (β = 0.21; p = 0.036). OH remained positively associated with CKD progression mediated by PEDF. OH is an independent risk factor for CKD progression in patients with T2DM. Our study supports the novel definition of PEDF as a positive mediator between OH and CKD progression.
Identifiants
pubmed: 33741351
pii: S0168-8227(21)00107-8
doi: 10.1016/j.diabres.2021.108754
pii:
doi:
Substances chimiques
Eye Proteins
0
Nerve Growth Factors
0
Serpins
0
pigment epithelium-derived factor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108754Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.